Allergy: TGFβ receptor mutations impose a strong predisposition for human allergic disease

Pamela A. Frischmeyer-Guerrerio, Anthony L. Guerrerio, Gretchen Oswald, Kristin Chichester, Loretha Myers, Marc K. Halushka, Maria Oliva-Hemker, Robert A. Wood, Harry C. Dietz

Research output: Contribution to journalArticlepeer-review

114 Scopus citations


Transforming growth factor-β (TGFβ) is a multifunctional cytokine that plays diverse roles in physiologic processes as well as human disease, including cancer, heart disease, and fibrotic disorders. In the immune system, TGFβ regulates regulatory T cell (Treg) maturation and immune homeostasis. Although genetic manipulation of the TGFβ pathway modulates immune tolerance in mouse models, the contribution of this pathway to human allergic phenotypes is not well understood. We demonstrate that patients with Loeys-Dietz syndrome (LDS), an autosomal dominant disorder caused by mutations in the genes encoding receptor subunits for TGFβ, TGFBR1 and TGFBR2, are strongly predisposed to develop allergic disease, including asthma, food allergy, eczema, allergic rhinitis, and eosinophilic gastrointestinal disease. LDS patients exhibited elevated immunoglobulin E levels, eosinophil counts, and T helper 2 (TH2) cytokines in their plasma. They had an increased frequency of CD4+ T cells that expressed both Foxp3 and interleukin-13, but retained the ability to suppress effector T cell proliferation. TH2 cytokine-producing cells accumulated in cultures of naïve CD4+ T cells from LDS subjects, but not controls, after stimulation with TGFβ, suggesting that LDS mutations support T H2 skewing in naïve lymphocytes in a cell-autonomous manner. The monogenic nature of LDS demonstrates that altered TGFβ signaling can predispose to allergic phenotypes in humans and underscores a prominent role for TGFβ in directing immune responses to antigens present in the environment and foods. This paradigm may be relevant to nonsyndromic presentations of allergic disease and highlights the potential therapeutic benefit of strategies that inhibit TGFβ signaling.

Original languageEnglish (US)
Article number195ra94
JournalScience translational medicine
Issue number195
StatePublished - Jul 24 2013

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Allergy: TGFβ receptor mutations impose a strong predisposition for human allergic disease'. Together they form a unique fingerprint.

Cite this